Literature DB >> 3335103

The effect of cryosurgery and polymethylmethacrylate in dogs with experimental bone defects comparable to tumor defects.

M M Malawer1, M R Marks, D McChesney, M Piasio, S F Gunther, B M Schmookler.   

Abstract

The effects of liquid nitrogen (LN) and polymethylmethacrylate (PMMA) on normal bone, bone graft incorporation, and reossification were evaluated by simulating a tumor in dogs with experimental bone cavity. Ten skeletally mature mongrel dogs (20 femora) were divided into three groups: Group I, controls; Group II, LN (with and without bone graft); and Group III, PMMA (with and without LN). Roentgenograms, whole-mount histology, and tetracycline fluorescence studies were performed on the distal femur. Correlation of these studies showed that (1) marked trabecular and bone necrosis, extending 7-12 mm around the circumference of the cavity, developed by three and seven weeks after LN but no bony necrosis occurred after PMMA; (2) the pattern of reossification following cryosurgery was delayed and abnormal, demonstrating increased calcification and metaplastic bone formation; (3) cryosurgery decreased the rate of bone graft incorporation; (4) the cryonecrotic rim following cryosurgery correlated with an abortive attempt at peripheral reossification; and (5) cryosurgery had no effect on the articular cartilage. Cryosurgery is effective in causing bone necrosis, whereas PMMA is not, and the pattern of reossification is delayed and altered by freezing. This study suggests that microvascular thrombosis with subsequent ischemic infarction of bone is a major cause of bone necrosis following cryosurgery.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3335103

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  17 in total

1.  Early results of a modified technique of cryosurgery.

Authors:  Nevzat Dabak; Yilmaz Tomak; Ahmet Piskin; Birol Gulman; Hakan Ozcan
Journal:  Int Orthop       Date:  2003-05-20       Impact factor: 3.075

2.  [Bone cysts-differential diagnosis and therapeutic approach].

Authors:  Markus Weber; Axel Hillmann
Journal:  Orthopade       Date:  2018-07       Impact factor: 1.087

3.  Cementation in the treatment of giant cell tumor of bone.

Authors:  S Komiya; A Inoue
Journal:  Arch Orthop Trauma Surg       Date:  1993       Impact factor: 3.067

Review 4.  A novel hyperthermia treatment for bone metastases using magnetic materials.

Authors:  Akihiko Matsumine; Kenji Takegami; Kunihiro Asanuma; Takao Matsubara; Tomoki Nakamura; Atsumasa Uchida; Akihiro Sudo
Journal:  Int J Clin Oncol       Date:  2011-03-04       Impact factor: 3.402

5.  Surgery for locally aggressive bone tumours.

Authors:  A Devitt; T O'Sullivan; M Kavanagh; B J Hurson
Journal:  Ir J Med Sci       Date:  1996 Oct-Dec       Impact factor: 1.568

6.  Extended intralesional treatment versus resection of low-grade chondrosarcomas.

Authors:  Chad Aarons; Benjamin K Potter; Sheila C Adams; J David Pitcher; H Thomas Temple
Journal:  Clin Orthop Relat Res       Date:  2009-01-14       Impact factor: 4.176

7.  No recurrences in selected patients after curettage with cryotherapy for grade I chondrosarcomas.

Authors:  Badio S Souna; Nicolas Belot; Hélène Duval; Frantz Langlais; Hervé Thomazeau
Journal:  Clin Orthop Relat Res       Date:  2010-01-07       Impact factor: 4.176

8.  MR appearance of skeletal neoplasms following cryotherapy.

Authors:  M L Richardson; L R Lough; W P Shuman; G D Lazerte; E U Conrad
Journal:  Skeletal Radiol       Date:  1994-02       Impact factor: 2.199

9.  An investigation of bone necrosis and healing after cryosurgery, phenol cautery or packing with bone cement of defects in the dog femur.

Authors:  Y H Yun; N H Kim; D Y Han; E S Kang
Journal:  Int Orthop       Date:  1993       Impact factor: 3.075

10.  Curettage of benign bone tumors without grafts gives sufficient bone strength.

Authors:  Takashi Yanagawa; Hideomi Watanabe; Tetsuya Shinozaki; Kenji Takagishi
Journal:  Acta Orthop       Date:  2009-02       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.